CBLB and melanoma: As Cbl-b−/− T cells were resistant to PD-L1 Ig-mediated regulation in vitro, we sought to test this in an in vivo B16 melanoma tumor model in which inhibiting the PD-L1/PD-1 pathway has been shown to prevent the outgrowth of liver metastases (30).